IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: November 2024

Volume 9 | Issue 11

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Solid Lipid Nanoparticle for Lansoprazole drug.
Authors Name: RAHUL SHARMA , MD SHAMS RAJA
Unique Id: IJSDR2410034
Published In: Volume 9 Issue 10, October-2024
Abstract: Solid lipid nanoparticles (SLNs) are an important class of noncolloidal drug delivery systems. This review covers several aspects of SLNs, including morphology, structural characteristics, preparation methods, and characterisation techniques. SLNs are essential for enhancing the medicinal effectiveness of medications in a variety of categories. SLNs are currently being used for cancer treatment, infectious diseases, diabetes, cardiovascular disease, central nervous system problems, and cosmeceuticals, among other things. Enhanced pharmacokinetics, controlled drug release, surface modification potential, increased penetration through biological barriers, resistance to chemical degradation, and the ability to encapsulate numerous therapeutic compounds at once are just a few of its noteworthy benefits. This review also highlights current research developments in the field of SLNs. Solid lipid nanoparticles (SLNs) have gained popularity since the 1990s and have become an inventive medication delivery technology. These nanoparticles can be made of different solid lipids, including fatty acids, waxes, and glycerides, and they can be stabilized using a wide range of surfactants. Scholars from all over the world are interested in them because of their originality and versatility. Compared to other colloidal carriers such as emulsions, liposomes, and polymeric nanoparticles, SLNs have many benefits. The number of research organizations creating SLN formulations and production methods customized for certain purposes is constantly growing.
Keywords: Solid lipid nanoparticles, carrier system, nanomedicine, biocompatibility, nanotechnology.
Cite Article: "Solid Lipid Nanoparticle for Lansoprazole drug.", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.9, Issue 10, page no.277 - 288, October-2024, Available :http://www.ijsdr.org/papers/IJSDR2410034.pdf
Downloads: 00017
Publication Details: Published Paper ID: IJSDR2410034
Registration ID:212596
Published In: Volume 9 Issue 10, October-2024
DOI (Digital Object Identifier):
Page No: 277 - 288
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner